Cargando…
Protein misfolding, amyotrophic lateral sclerosis and guanabenz: protocol for a phase II RCT with futility design (ProMISe trial)
INTRODUCTION: Recent studies suggest that endoplasmic reticulum stress may play a critical role in the pathogenesis of amyotrophic lateral sclerosis (ALS) through an altered regulation of the proteostasis, the cellular pathway-balancing protein synthesis and degradation. A key mechanism is thought t...
Autores principales: | Bella, Eleonora Dalla, Tramacere, Irene, Antonini, Giovanni, Borghero, Giuseppe, Capasso, Margherita, Caponnetto, Claudia, Chiò, Adriano, Corbo, Massimo, Eleopra, Roberto, Filosto, Massimiliano, Giannini, Fabio, Granieri, Enrico, Bella, Vincenzo La, Lunetta, Christian, Mandrioli, Jessica, Mazzini, Letizia, Messina, Sonia, Monsurrò, Maria Rosaria, Mora, Gabriele, Riva, Nilo, Rizzi, Romana, Siciliano, Gabriele, Silani, Vincenzo, Simone, Isabella, Sorarù, Gianni, Volanti, Paolo, Lauria, Giuseppe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5724081/ https://www.ncbi.nlm.nih.gov/pubmed/28801400 http://dx.doi.org/10.1136/bmjopen-2016-015434 |
Ejemplares similares
-
Erythropoietin in amyotrophic lateral sclerosis: a multicentre, randomised, double blind, placebo controlled, phase III study
por: Lauria, Giuseppe, et al.
Publicado: (2015) -
The unfolded protein response in amyotrophic later sclerosis: results of a phase 2 trial
por: Dalla Bella, Eleonora, et al.
Publicado: (2021) -
G-CSF (filgrastim) treatment for amyotrophic lateral sclerosis: protocol for a phase II randomised, double-blind, placebo-controlled, parallel group, multicentre clinical study (STEMALS-II trial)
por: Salamone, Paolina, et al.
Publicado: (2020) -
Comparative Analysis of C9orf72 and Sporadic Disease in a Large Multicenter ALS Population: The Effect of Male Sex on Survival of C9orf72 Positive Patients
por: Trojsi, Francesca, et al.
Publicado: (2019) -
Proteostasis and ALS: protocol for a phase II, randomised, double-blind, placebo-controlled, multicentre clinical trial for colchicine in ALS (Co-ALS)
por: Mandrioli, Jessica, et al.
Publicado: (2019)